Perla Colunga

New publication 📢 Very exciting news about Nivo for HL over the last months, unfortunately its access is still troubling in LATAM. Here we report our center's experience with reduced doses of Nivo in r/r HL ✅73% ORR ✅43% CR link.springer.com/article/10.100…

🚨 ¡Comienza la Serie 18 en Español de WiL! 🗓 6 mayo 2026 🎓 Diagnóstico en linfomas no Hodgkin: lo clave en la práctica clínica 👩‍⚕️ Dra. Marcela de Dios Soler + Dra. Leticia Quintanillas 🔗 Sumate: #Linfoma #Hematología #WiL

Coming soon: #WiLingWednesdays Series 18 – LATAM Series Free educational webinars in Spanish featuring global experts, with a special focus on Latin America 📅 May–June 2026 🌍 Women in Lymphoma: one global community, one shared purpose 💜

Transplant is very hard to implement in LMICs. We have done it through hard work, creativity, clinical research and institutional support. Fact accredited, now working hard to implement #CARTcells. The @TheEBMT made a video about our transplant program. Watch it here: youtube.com/watch?v=_OVxFY…

In the US we argue CAR-T vs bispecifics while 36% of Latin America fights for access to rituximab. Let that sink in. GELL Survey 2025 — 73 centers, 16 countries: 73% highly restricted access to bispecifics ~0% commercial CAR-T outside Brazil Only 15% have NGS Only 35% access to clinical trials We’re having 2026 debates with early 2000s access. The real question isn’t CAR-T vs bispecifics. It’s: how do we close this gap? Sobering data presented by @DrMCanales here in Chile. @LymphomaEx Colunga-Pedraza et al. Blood 2025;146(Suppl 1):6193 #Lymphoma #DLBCL #LATAM #GlobalOncology #HealthEquity

@rennquevedo Felicidades !!

Grateful for everyone who’s been part of this journey. I matched into Internal Medicine 🫶🏼🥹 #Match2026

@DrRaulCordoba @MDAnderson_ES Felicidades Doctor!! Mucho éxito

🎉 I’m happy to announce that I’m starting a new position at the Department of #Hematology at ⁦@MDAnderson_ES⁩

Danazol treatment for poor graft function after hematopoietic stem cell transplantation: a single centre experience @BMTjournal nature.com/articles/s4140…

Mentorship and Community at the Women in Lymphoma Meeting - Perla Colunga (@PerlaRcp) @WomenInLymphoma @DrCarlaCasulo oncodaily.com/voices/428764 #OncoDaily #Oncology #Cancer #Health #Medicine

One week ago at #ASH25, the Women in Lymphoma meeting @WomenInLymphoma . Grateful for the opportunity to receive mentorship from @DrCarlaCasulo. Already looking forward to 2026.

Important conclusions were drawn from this study: 1. There's a gigantic room for improvement in outcome definition, selection, and implementation in ITP clinical trials 2. Friendship and brightly kind mentorship are a great motor for science Happy for this incredible humans

So privileged to share office, laughs, friendship, ideas, work, advice, worries, victories, and every single up and down with these two incredible women Thanks for being such an exemplary role model and mentor @PerlaRcp HBD Ale!! Always better to do science with a great friend

Lucky us we got the best @PerlaRcp #ASH25

Couldn’t agree more 👁️

Happy to share our work #ASH25, in collaboration with @GELL_Group! Lymphoma care has advanced — but access remains unequal. 70+ Latin America centers: -Limited access to clinical trials -CAR-T in only 8% -Novel therapies highly restricted Closing these gaps must be a priority

@sofiarivarolac @Grupo_GELL Congrats Sofia

I’m very proud to present a poster on follicular lymphoma, data from LATAM on ASH2025 🇦🇷@Grupo_GELL #ASH2025

#ASH25 Stop today by our poster No: 4508 “Effectiveness of comprehensive geriatric assessment (CGA) in older patients with diffuse large B-cell #lymphoma and the impact of #frailty in treatment tolerability and survival in a prospective, multicenter study.” #geriheme #lymsm

Finally had an opportunity to meet with the transplant 🐐 himself @NicoGagelmann you are officially invitated to Monterrey's team carne asada 🇲🇽 Very refreshing to meet enthusiastic scientists

Always a special moment to present insights from our people along your mentor @PerlaRcp and friend @a_delasfuentes and with great feedback from @DrRaulCordoba And of course the crowds gathered around our lymphoma team leader! So privileged to have her advise daily

Ale, you’re a 🔝 researcher. Thank you for your hard work!